Trial Profile
A Randomized, Double-Blind Placebo-Controlled, Parallel Group Study to Study the Efficacy and Tolerability of Ramelteon (Rozerem) in the Prophylaxis of Migraine.
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 12 Jun 2013
Price :
$35
*
At a glance
- Drugs Ramelteon (Primary)
- Indications Migraine
- Focus Therapeutic Use
- 22 Aug 2012 Status changed from completed to discontinued as reported by ClinicalTrials.gov.
- 05 Oct 2010 Actual end date (Sep 2010) added as reported by ClinicalTrials.gov.
- 05 Oct 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.